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ABSTRACT 
Systematic screening for diabetic retinopathy using retinal photography has been shown to reduce the incidence 
of blindness among people with diabetes. The implementation of diabetic retinopathy screening programmes 
faces several challenges. Consequently, methods for improving the efficiency of screening are being sought, one 
of which is the automation of image grading involving detection of images with either disease or of inadequate 
quality using computer software. This review aims to bring together the available evidence that is suitable for 
making a judgement about whether automated grading systems could be used effectively in diabetic retinopathy 
screening. To do this, it focuses on studies made by the few centres who have presented results of tests of 
automated grading software on large sets of patients or screening episodes. It also considers economic model 
analyses and papers describing the effectiveness of manual grading in order that the effect of replacing stages of 
manual grading by automated grading can be judged. In conclusion, the review shows that there is sufficient 
evidence to suggest that automated grading, operating as a disease / no disease grader, is safe and could reduce 
the workload of manual grading in diabetic retinopathy screening.  
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INTRODUCTION 
Early detection of diabetic retinopathy allows this disease to be treated before it becomes symptomatic so that 
sight loss can be limited. In the UK, diabetic retinopathy screening is run by the NHS aiming to reduce the 
incidence of blindness in people with diabetes and is based on digital photography and slit-lamp examination for 
technical failures [1]. 
Typically around 70% of screened patients are normal [2], and hence the initial grading task is to perform 
disease / no disease grading, identifying and removing all normal images and retaining those with some disease 
or other abnormality for further scrutiny. This is followed by one or more stages of full-disease grading and 
possibly arbitration grading. The scale of this task is huge; in the UK screening programmes there are 
approximately two million retinal image sets that require grading each year. Therefore, computer automation 
has been considered to assist the grading process [3,4]. 
The intention of this review is to guide potential users of automated retinopathy grading about whether current 
systems are suitable for introduction into screening. Therefore it only includes papers on automated disease 
detection that cover studies on large datasets similar to what would be found in a screened population.  
A section on manual grading is also included since a decision on which of the alternative systems will provide 
the greatest benefit requires knowledge of the performance of each option. 
Indications for the feasibility of automated grading  
Most regional screening programmes generate tens to hundreds of thousands of images to be graded each year. 
Computers excel at repetitive tasks and, if the necessary infrastructure is in place, it is likely that computer 
grading will be cheaper than manual grading. There are several indications that computers would be capable of 
this task; 
 Even if a computer is only capable of grading at a disease / no disease level, this would still provide a 
large reduction in the manual grading workload. This is because a large proportion of the patients 
attending diabetic retinopathy screening are normal.  
 The images are relatively constrained in that normal images show a very standard structure. They are 
also uncluttered in that lesions are usually separate from normal features.  
 The digital network infrastructure is already in place that could allow centralised computer processing 
of screening programme images. 
In addition, over the last two decades, many research groups have shown that it is possible to develop software 
that, in small tests, can identify retinal lesions to a high accuracy and details may be found in previous reviews 
that have focussed mainly on the algorithms involved [5-8]. However only large studies can inform decisions on 
the introduction of automated grading into screening since there is no certainty that the performance found using 
a small image set will be maintained in practice. 
The role that automated grading may play in screening is open to debate. Since most of the available evidence 
relates to automated “disease / no disease” grading, this will be the main emphasis of this article. However, a 
section is devoted to other roles. 
Terminology 
The term “referable retinopathy” is used here to mean retinopathy, including maculopathy, more serious than 
mild non-proliferative retinopathy as defined by the Early Treatment of Diabetic Retinopathy Study scheme [9] 
or background retinopathy in the English or Scottish schemes [10,11]. The term “maculopathy” is used to mean 
the presence of photographic surrogate markers indicative of macula oedema requiring more frequent 
observation than the standard screening interval or referral to ophthalmology [10,11]. 
 4 
Grading roles of “disease / no disease” grading and “full disease” grading are explained in the UK National 
Screening Committee Workbook [10]. The process of disease / no disease grading separates episodes showing 
any disease or abnormality from those which are normal. Full disease grading takes place after disease / no 
disease grading and identifies episodes requiring a clinical outcome which is not recall at the default screening 
interval. It assigns a grade according to disease severity. 
METHODS - SELECTION OF STUDIES  
A search was made for peer-reviewed studies from journals using ISI Web of Knowledge with the specification 
for paper topic:  
(automat* OR comput*) AND (detection OR diagnosis OR grading) AND diabet* AND retinopathy.  
The search found 747 papers and these were manually examined using the title and abstract to find those whose 
main topic was automated grading or computer detection of diabetic retinopathy and its associated signs in 
retinal photographs. This resulted in 82 papers. The following selection criteria were then used to select those 
which may be suitable to draw conclusions on the use of automated retinopathy grading within healthcare: 
1. The study should be an assessment of an automated image analysis system applied to detection of 
retinopathy in retinal photographs.  
2. The results should be reported for referable retinopathy on a per-patient or per-episode basis, or it 
should be based on such data.  
3. The study should be based on tests with at least 200 subjects with and 200 without referable 
retinopathy.  
Criterion 3 means that sensitivity and specificity for detection of referable retinopathy can be estimated with a 
confidence interval of less than ±5% at a sensitivity or specificity of 90%. Seven papers satisfied criteria 1 and 2 
but were rejected because of study size [12-18] with the largest having 95 [12] patients with referable 
retinopathy.  
The remaining papers were divided into efficacy studies reporting original results for the sensitivity or 
specificity for detection of referable retinopathy and economic studies describing economic analysis based on 
efficacy results presented elsewhere.  
THE EVIDENCE 
Six efficacy studies and two economic studies were identified that satisfy the above criteria and are based on 
three systems, Utrecht / Iowa, Aberdeen and Brest, as shown in table 1. Only the Utrecht / Iowa and Aberdeen 
systems can be considered complete automated grading systems since only these have an image quality 
assessment module. Table 2 shows the performances demonstrated in each paper and includes further study 
details. 
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Table 1: Details of the automated systems described in studies listed in table 2. Two of the systems contain 
multiple modules; however, not all studies used all modules. 
References System Developed at Photographic 
protocol used 
Modules 
Abramoff 2008 [19] 
Niemeijer 2009 [20] 
Abramoff 2010 [21] 
Utrecht / 
Iowa 
Image Sciences 
Institute Utrecht 
and University of 
Iowa 99.5% 
Two fields per eye, 
mydriasis as 
required. 
Red lesion detection 
Exudate detection  
Assessment of quality 
Philip 2007 [22] 
Scotland 2007 [23] 
Fleming 2010 [24] 
Scotland 2010 [25] 
Fleming 2010 [26] 
Aberdeen University of 
Aberdeen 80% 
One field per eye, 
mydriasis as 
required. 
Microaneurysm detection 
Haemorrhage detection 
Exudates detection 
Assessment of quality 
Abramoff 2010 [21] Brest Brest University 
Hospital, France 
Two fields per eye, 
mydriasis as 
required. 
Microaneurysm detection 
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Table 2: Studies on automated image analysis in diabetic retinopathy that satisfy the selection criteria. Study size is given along with the number of cases having referable retinopathy. 
Study Type of 
study 
Automated system details Study size 
(referable 
retinopathy) 
Case selection strategy Detection rates Specif-
icity 
Philip et al 2007 
[22] 
Efficacy Aberdeen system: microaneurysm detection 
and quality assessment 
6672 (330) Screening programme 
cohort – all cases included 
Referable retinopathy / ungradable cases 98.9%*  
Referable retinopathy 97.9% 
Mild retinopathy 80.9% 
Ungradable cases 99.5% 
52.4%* 
Scotland et al 
2007 [23] 
Economic 
modelling 
As for Philip 2007 [17] 
Abramoff et al 
2008 [19] 
Efficacy Utrecht / Iowa system: 
haemorrhage/microaneurysm and exudate 
detection and quality assessment 
7689 (378) Screening programme 
cohort – ungradable cases 
removed 
Referable retinopathy 84.4%* 
Ungradable cases 80% 
 
64.3%* 
Niemeijer et al 
2009 [20] 
Efficacy Utrecht / Iowa system: 
haemorrhage/microaneurysm and exudate 
detection and quality assessment 
15000 (394) Screening programme 
cohort – all cases included 
Referable retinopathy / ungradable cases 93.0% 60.0% 
Fleming et al 
2010 [24] 
Efficacy 
(automated 
system 
comparison) 
Aberdeen system: (1) microaneurysm 
detection and (2) microaneurysm, 
haemorrhage and exudate  detection and 
quality assessment 
7568 (1253) Screening programme – 
stratified selection 
Referable retinopathy / ungradable cases 97.3%* 
Referable retinopathy 96.9% 
Mild retinopathy 79.0% 
Maculopathy 95.4%* 
Proliferative referable retinopathy 97.4% 
Non-proliferative referable retinopathy 98.9% 
Ungradable cases 98.8% 
49.0% 
Scotland et al 
2010 [25] 
Economic 
modelling 
As for Fleming 2010 [21] 
Abramoff et al 
2010 [21] 
Efficacy 
(automated 
system 
comparison) 
(1) Utrecht / Iowa system: haemorrhage/
microaneurysm detection (possibly 
combined with quality assessment*); 
(2) Brest system: microaneurysm detection. 
15980 (793) Screening programme 
cohort – ungradable cases 
removed 
Utrecht/Iowa system  
Referable retinopathy 90.0% 
Brest system  
Referable retinopathy 90.0% 
 
47.7% 
 
43.6% 
Fleming et al 
2010 [26] 
Efficacy Aberdeen system: microaneurysm detection 
and quality assessment 
33535 (2214) Screening programme 
cohort – all cases included 
Referable retinopathy / ungradable cases 98.8%  
Referable retinopathy 97.8%* 
Mild retinopathy 83.9% 
Maculopathy 97.3% 
Proliferative referable retinopathy 100% 
Non-proliferative referable retinopathy 100% 
Ungradable cases 99.8% 
41.1%* 
*The paper does not make it clear whether quality assessment was included or not. 
*Calculated from figures in the paper but not reported directly therein. 
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 The efficacy of automated grading  
Table 2 illustrates that the Aberdeen system achieved higher sensitivities than the Utrecht / Iowa system for 
referable retinopathy (including ungradable cases) though the average specificity over the papers was lower for 
the Aberdeen system. When comparing sensitivities and specificities it should be borne in mind that there is a 
trade-off between sensitivity and specificity. (During development, the sensitivity of a system can be increased 
at the expense of specificity and vice versa.) A comparison between two systems is difficult, except where they 
are tested in the same study, because the study populations are different and because different people created the 
reference grading. Only one direct comparison has been made between two systems, the Utrecht/Iowa and Brest 
systems [23]. This considered disease in gradable images. The Utrecht / Iowa and Aberdeen systems have been 
designed in the context of different photographic protocols; the Utrecht / Iowa system is based on a protocol 
used in the Netherlands with two photographs per eye while the Aberdeen system is based on the Scottish 
protocol with a single field per eye. 
Detection rates for proliferative retinopathy have been reported only for the Aberdeen system and was found to 
be 100% [22,26] and 97.4% [24]. These studies reported detection rates for maculopathy to be 97.3%, 97.8% 
and 95.4% (calculated figures) respectively. 
Three of the studies avoided selection criteria that required examination of the images, one using the Utrecht / 
Iowa system [20] and two using the Aberdeen system [22,26]. Unfortunately, one of these has limited data on 
clinical performance because it is published in a technical journal [20]. Two studies with the Utrecht / Iowa 
system involved removal of ungradable cases in a major part of the analysis and one study with the Aberdeen 
system involved data stratified according to whether retinopathy was referable or not [24]. 
One study with the Aberdeen system used 7 graders to arbitrate the false negatives of automated grading 
compared to the screening programme manual grading and thereby provided a consensus grade for these images 
[26]. It showed that no cases of non-maculopathy referable retinopathy were missed by the automated system 
and that the detection rate for maculopathy was 97.8%. An analysis was also made of false negatives with the 
Utrecht / Iowa system [19]; of 87 missed cases of referable retinopathy according to the manual grading, 24 had 
large haemorrhages or neovascularisation, 23 had small haemorrhages, 18 had exudates or cottonwool spots and 
22 were not diabetic retinopathy according to a second expert. In Philip et al 2007, two false negative eyes, 
graded as having proliferative retinopathy but missed by the Aberdeen system, were found to have only mild 
diabetic retinopathy at eye clinic examination [22]. 
Two studies using different systems have looked at the relative benefits of using detectors for the various dot-
lesion types. For the Utrecht / Iowa system it was found that detection of referable retinopathy (including 
maculopathy) is improved by using a combination of bright and red lesion detectors rather than the individual 
detectors [20]. These results are compatible with those reported for the Aberdeen system which had significantly 
better detection of referable retinopathy when using microaneurysm, haemorrhage and exudate detection in 
combination compared to using microaneurysm detection alone [24]. The improvement was specifically for the 
maculopathy cases. For proliferative retinopathy, the addition of haemorrhage and exudate detection had no 
effect on performance.  
All of the studies listed in table 1 used dot-lesion detection; vascular abnormalities were not explicitly detected. 
This suggests that detection of dot-lesions, without detection of vascular abnormalities, is sufficient for referable 
retinopathy detection. 
The efficacy of manual grading 
The impact of replacing part of manual grading with automated grading can only be known if the efficacy of 
both manual and automated grading is known.  
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The evidence concerning the “reliability”, meaning the reproducibility, of manual grading has been reviewed in 
Benbassat and Polak 2009 [27]. The results of the reviewed studies show that reproducibility of grading is very 
rarely 100%, implying also that sensitivity is below 100%. 
Table 3: Results of studies assessing sensitivity and specificity of manual grading of referable retinopathy. 
Papers using the term “sight threatening retinopathy” were included. 
Study Total study size 
(number with 
referable retinopathy) 
Sensitivity 
% 
Specificity 
% 
Notes 
Liesenfeld 2000 [28] 115 (13) 85 90 Median of 6 results 
Olson 2003 [29] 545 (55) 93 87  
Stellingwerf 2004 [30] 197 (70) 86 
92 
93 
93 
Results for TIFF images 
Arun 2006 [31] 498 (62) 93.5 97.8  
Ruamviboonsuk 2006 
[32] 
400 (44) 93 
100 
97 
73 
Best sensitivity and 
specificity results are given 
Philip 2007 [22] 6722 (330) 99.1 73.9*  
Abramoff 2008 [19] 500 (unknown) 62 
85  
84 
89 
Best sensitivity and 
specificity results are given 
* Calculated from figures in the paper but not reported directly therein. 
Some example results for studies that reported sensitivity and specificity of manual grading for referable 
retinopathy are given in table 3. Sensitivity and specificity are easier to interpret than kappa agreement 
coefficient which, though used by many authors, has the disadvantage that it is affected by prevalence. It should 
be borne in mind that the reference for these assessments is itself a judgement, though hopefully produced in a 
more robust manner than the grading being assessed. It is likely that there are great differences in performances 
between professional groups and between individuals as suggested by Ruamviboonsuk et al 2006 [32]. This and 
two other studies compared multiple graders on the same image set [19,30]. Philip et al 2007 is the only study to 
satisfy the size criterion applied in this review for selection of studies on automated grading. 
Cases of referable retinopathy are not only missed during grading; they are also missed due to the nature of 
digital photography. Scanlon et al 2003 measured the sensitivity and specificity for digital photography against 
slit-lamp biomicroscopy [33]. These were 87.8%, and 86.1%, respectively, for mydriatic 2-field photography.  
Comparing automated and manual grading 
A direct comparison of automated and manual grading, using the same dataset, has been made only in one study 
[22]. Both automated and manual graders were operating as disease / no disease graders. For the manual system, 
a sensitivity of 99.1% was reported for detection of referable retinopathy at a specificity of 73.9% (calculated 
figure). For automated grading the sensitivity was 97.9% at specificity 52.4% (calculated figure). The difference 
between automated and manual grading sensitivities for referable retinopathy was not statistically significant at 
the 5% level. For mild retinopathy and for ungradable images, the automated system had higher sensitivity than 
the manual system.  
The sensitivities and specificities of detection of referable retinopathy by manual graders and by automated 
grading as listed in tables 2 and 3 are displayed in figure 1. Specificity is consistently higher for manual 
compared to automated grading. This suggests that automated grading cannot completely replace manual 
grading but, because automated grading has a high sensitivity, it could safely reduce workload.  
The following considerations should be taken into account when comparing the results shown in figure 1.  
Firstly, some of the manual grading results displayed in table 3 and figure 1 may have been from graders 
operating at a level of specificity which is suitable as the final specificity of screening; this is a level at which 
ophthalmology services are not swamped by unnecessary referrals. A trade-off exists between sensitivity and 
specificity and so this specificity may only be possible by operating at lower levels of sensitivity.  
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Secondly, the lower specificity of the automated grading systems compared to manual grading means that 
patients in which automated grading detected any abnormality would have to be referred to manual grading. 
Therefore, a combined automated and manual grading system would be necessary so that the specificity of the 
screening programme is acceptable. However, the sensitivity of multiple sequential grading stages is inevitably 
lower than the sensitivity of any individual stage. A comparison between the combined performances of 
complete grading systems would be more useful than a comparison of the individual grader performances that 
are shown in figure 1.  
 
Figure 1. Specificity and sensitivity, presented in Receiver Operator Characteristics curve format, for detection 
of referable retinopathy as reported in the studies listed in tables 2 and 4. The point labelled by an asterisk is for 
a study which reported results only for referable retinopathy and ungradable cases grouped together [20]. 
The economics of automated grading  
Modelling of complete grading systems was described in two economic analyses, linked to two of the efficacy 
studies for the Aberdeen system. These modelled a system consisting of a combination of automated and manual 
grading and a fully manual system. Scotland et al 2007 [23] used the efficacy figures reported in Philip et al 
2007 [22] and predicted that replacement of manual disease / no disease grading by an automated system would 
result in a cost saving of around £200,000 when scaled to the population of Scotland [18]. The lower specificity 
of automated compared to manual grading would mean that a greater number of full disease gradings must be 
performed. Nonetheless the overall workload would be reduced.  
The efficacy results presented in Fleming et al 2010 [24] were also subject to economic analysis in Scotland et 
al 2010 [25]. This concluded that inclusion of exudate and haemorrhage detection produces a more cost-
effective algorithm compared to microaneurysm detection alone (£68 additional cost per additional case of 
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referable retinopathy detected). It also found that automated grading would significantly reduce grading costs by 
£212,695 in Scotland.  
Other roles for automated grading 
The efficacy results for automated grading are most easily interpreted in terms of a disease / no disease grading 
role. This section looks briefly at other possible roles. 
Full disease grading: A full-disease grader must operate with specificity above what can be achieved by 
automated grading. Therefore, this role does not seem to be achievable by current systems. 
Verification grading: An automated system working in parallel with and as a verification of manual grading 
has been suggested as the role of automated image analysis in screening for breast cancer [34]. A similar role 
may be considered useful for automated retinopathy grading. Given that full-disease grading is not practical by 
existing automated grading systems, this would have to be at a disease / no disease level. There would be more 
discrepancies than there would be from manual graders verifying each other since automated grading produces 
more false positive results than manual grading. 
Quality assurance: Another possible role for automated grading is quality assurance since this is a significant 
component of the work involved in the maintenance of a screening programme [35]. Internal quality assurance 
requires checking samples of grading results which are large enough to detect suboptimal performance by 
graders. Automated grading in this role might reduce, but probably not eliminate, the burden of manual quality 
assurance grading. Before automated grading is used in this role, it would be essential to know the ability of 
automated grading to detect images which were manual grading failures; on average, these are probably more 
difficult than routine cases. Such a test would be easy to perform but does not seem to have been reported.  
Manual grading assistant: To assess the performance of automated grading as an assistant to manual grading, 
it would be necessary to test the performance of manual graders with and without this assistance. Does 
automated lesion detection assist manual graders or does giving attention to the additional information provided 
by automated grading increase their work? Studies on this issue do not seem to have been reported. 
CONCLUSIONS 
This review has evaluated the evidence on whether automated grading systems could be used effectively in 
diabetic retinopathy screening. 
Automated grading using detectors of multiple types of dot lesions shows increased performance compared to 
automated grading using a detector of a single lesion type. However, this improvement may be restricted to the 
detection of maculopathy; microaneurysm detection is capable of detecting 100% of cases of proliferative 
retinopathy.  
The most likely role for automated grading appears to be disease / no disease grading.  
Automated grading has been shown to have very high detection rates for referable retinopathy and for 
ungradable cases. For the Aberdeen system, the detection rate for proliferative retinopathy approaches 100%. 
There is no evidence that the replacement of manual grading by automated grading would reduce the detection 
rates for disease. Studies on manual grading show that detection rates are well below 100%.  
The specificity of automated grading is lower than for manual grading. Despite this, the specificity of automated 
grading is sufficiently high to provide a substantial workload reduction to manual grading from which cost 
savings would be expected. 
From economic modelling based on large effectiveness studies, it appears that automated disease / no disease 
grading would result in savings both to running costs and to workload. 
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